Dergi makalesi Açık Erişim
Dost, Turhan
{ "conceptrecid": "8860", "created": "2021-03-15T07:05:21.996855+00:00", "doi": "10.1007/s43440-019-00046-5", "files": [ { "bucket": "d6bb1411-ae62-4236-b4bb-a5dd650e870e", "checksum": "md5:37d8d0e77e0fc93304b772e60b00d1d8", "key": "bib-1081195a-a3a3-49e4-9ff0-25fefe400afb.txt", "links": { "self": "https://aperta.ulakbim.gov.tr/api/files/d6bb1411-ae62-4236-b4bb-a5dd650e870e/bib-1081195a-a3a3-49e4-9ff0-25fefe400afb.txt" }, "size": 178, "type": "txt" } ], "id": 8861, "links": { "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.1007/s43440-019-00046-5.svg", "bucket": "https://aperta.ulakbim.gov.tr/api/files/d6bb1411-ae62-4236-b4bb-a5dd650e870e", "doi": "https://doi.org/10.1007/s43440-019-00046-5", "html": "https://aperta.ulakbim.gov.tr/record/8861", "latest": "https://aperta.ulakbim.gov.tr/api/records/8861", "latest_html": "https://aperta.ulakbim.gov.tr/record/8861" }, "metadata": { "access_right": "open", "access_right_category": "success", "communities": [ { "id": "tubitak-destekli-proje-yayinlari" } ], "creators": [ { "affiliation": "Adnan Menderes Univ, Med Sch, Dept Med Pharmacol, TR-09100 Aydin, Turkey", "name": "Dost, Turhan" } ], "description": "Objective The effects of prasugrel, a third-generation thienopyridine, on myocardial infarction, and ischemia-induced ventricular arrhythmias was evaluated in open-chest anesthetized rats. The role of protein kinase C and phosphoinositide 3-kinase pathways in these effects was also examined. Methods The effect of P2Y(12) receptor inhibition by prasugrel (3-10 mg/kg, po) on infarct size after 30-min coronary artery occlusion and 120-min reperfusion or on arrhythmias after 7-min coronary occlusion and 7-min reperfusion was evaluated. Results In the control group, 31.25 +/- 3.01% of the risk zone infarcted. At both prasugrel doses, infarct size was significantly smaller than that in the control group: 5.03 +/- 0.81% for 3 mg/kg (p < 0.0001), and 8.78 +/- 2.04% for 10 mg/kg (p < 0.0001). The protein kinase C antagonist chelerythrine abolished the anti-infarct effect of prasugrel at 24.77 +/- 1.73% as did the phosphoinositide 3-kinase antagonist wortmannin abolished the anti-infarct effect of prasugrel at 27.45 +/- 2.74%. Ten mg/kg prasugrel reduced the duration of VT (p = 0.0152 vs control), and wortmannin, but not chelerythrine, reversed the effect of prasugrel on arrhythmias (p = 0.0295). Conclusion The selective P2Y(12) inhibitor prasugrel provides effective protection against myocardial infarction and ischemia-induced ventricular arrhythmias in rats. As in ischemic postconditioning, protein kinase C and phosphoinositide 3-kinase signaling pathways play a role in this protection. Graphic abstract", "doi": "10.1007/s43440-019-00046-5", "has_grant": false, "journal": { "issue": "3", "pages": "672-679", "title": "PHARMACOLOGICAL REPORTS", "volume": "72" }, "license": { "id": "cc-by" }, "publication_date": "2020-01-01", "relations": { "version": [ { "count": 1, "index": 0, "is_last": true, "last_child": { "pid_type": "recid", "pid_value": "8861" }, "parent": { "pid_type": "recid", "pid_value": "8860" } } ] }, "resource_type": { "subtype": "article", "title": "Dergi makalesi", "type": "publication" }, "title": "Cardioprotective properties of the platelet P2Y(12) receptor inhibitor prasugrel on cardiac ischemia/reperfusion injury" }, "owners": [ 1 ], "revision": 1, "stats": { "downloads": 4.0, "unique_downloads": 4.0, "unique_views": 17.0, "version_downloads": 4.0, "version_unique_downloads": 4.0, "version_unique_views": 17.0, "version_views": 17.0, "version_volume": 712.0, "views": 17.0, "volume": 712.0 }, "updated": "2021-03-15T07:05:22.039637+00:00" }
Görüntülenme | 17 |
İndirme | 4 |
Veri hacmi | 712 Bytes |
Tekil görüntülenme | 17 |
Tekil indirme | 4 |